RETA

RETATRUTIDE (RETA)

Type: Synthetic multi-receptor peptide (triple agonist)

Description:
Retatrutide is a synthetic peptide analog engineered for laboratory research involving multi-receptor signaling and metabolic pathway analysis. It is designed to interact with multiple receptor systems simultaneously, making it a valuable tool for studying complex signaling networks and pathway integration within controlled experimental environments.

In research and preclinical models, retatrutide is utilized to examine GLP-1, GIP, and glucagon receptor interactions, as well as their combined effects on cellular signaling, energy regulation pathways, and receptor cross-talk. Its multi-target structure allows researchers to investigate synergistic signaling effects, pathway modulation, and structure–activity relationships across interconnected biological systems.

Research Areas of Interest:

• Multi-receptor signaling pathway research
• GLP-1, GIP, and glucagon receptor interaction studies
• Metabolic pathway and energy regulation modeling
• Peptide–receptor binding and signaling synergy analysis
• Structure–activity relationship (SAR) research